[Clinical and instrumental evaluation of the effect of tiapride in senile involutional syndrome].

Twenty elderly patients with pathological cerebral involution were treated with tiapride (200 mg/die) and investigated with psycho-clinical tests. After three months, the group of patients demonstrated a significant improvement compared to a control group treated with placebo.